Results 21 to 30 of about 8,980 (210)

Single versus multiple hyperthermic intraperitoneal chemotherapy applications for T4 gastric cancer patients: Efficacy and safety profiles

Frontiers in Oncology, 2023
ObjectiveTo explore the clinical safety and efficacy of single and multiple applications of lobaplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with T4 gastric cancer and to evaluate the impact of HIPEC on peritoneal ...
Jing Zhang, Yuemin Sun, Xiaofeng Bai, Peng Wang, Liang Tian, Yantao Tian, Yuxin Zhong   +6 more
doaj   +1 more source

Therapeutic Value of Hyperthermic Intraperitoneal Chemotherapy on Non-radical Appendiceal Low-grade Pseudomyxoma Peritonei

Zhongliu Fangzhi Yanjiu, 2020
Objective To explore the application value of hyperthermic intraperitoneal chemotherapy(HIPEC) on non-radical appendiceal low-grade pseudomyxoma peritonei(PMP).
SHI Guanjun, XIA Ao, AN Lubiao, ZHAI Xichao, MA Ruiqing, LU Yiyan, PANG Shaojun, CAI Ying, WANG Bing, CHEN Feng, XU Hongbin   +10 more
doaj   +1 more source

Hyperthermic intraperitoneal chemotherapy for patients with gastric cancer based on laboratory tests is safe: a single Chinese center analysis

BMC Surgery, 2022
Purpose About 15%—40% of gastric cancer patients have peritoneal metastasis, which leads to poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) is considered to be an effective treatment for these patients. This study evaluated the efficacy
Yunzi Wu, Xiaohao Zheng, Chunyang Sun, Shenghui Wang, Shikang Ding, Ming Wu, Jing Zhang, Bingzhi Wang, Liyan Xue, Lin Yang, Yantao Tian, Yibin Xie   +11 more
doaj   +1 more source

Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov [PDF]

, 2023
Introduction: Over the past two decades, cytoreductive surgery and HIPEC has improved outcomes for selected patients with peritoneal metastasis from various origins.
Lehmann, Kuno, Kristjan Ukegjini, Marisa Guidi, Thomas Steffen, Cihoric, Nikola, Ukegjini, Kristjan, Guidi, Marisa, Nikola Cihoric, Putora, Paul Martin, Krisztian Süveg, Paul Martin Putora, Steffen, Thomas, Süveg, Krisztian, Kuno Lehmann   +13 more
core   +2 more sources

Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Is Safe and Efficacious in Recurrent and Advanced Ovarian Cancer

Graduate Medical Education Research Journal, 2020
Mentor: Jason Foster Program: General Surgery Type: Original Research Background: HIPEC with cisplatin in recurrent and advanced ovarian cancer (AOC) improves survival, but renal toxicity is common, even with renal protectants.
Chunmeng Zhang, Ryan Mikus, Dalton Hegeholz, Valerie Shostrom, Abraham Matthews, James Commers, Laura Lambert, Jason Foster   +7 more
doaj   +1 more source

Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study

Frontiers in Oncology, 2022
To evaluate the additive effects of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval debulking surgery (IDS) in patients with advanced-stage ovarian cancer.
Yong Jae Lee, Ki Eun Seon, Dae Chul Jung, Jung-Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim   +7 more
doaj   +1 more source

PIPAC – Pressurized Intraperitoneal Aerosole Chemotherapy, HIPEC oder PIPAC? [PDF]

, 2021
Eine lokale, intraperitoneale Verabreichung von Chemotherapeutika ist ein naheliegendes Therapiekonzept des Ovarialkarzinomes, welches in der Mehrzahl der Patientinnen in einem fortgeschrittenen, peritoneal metastasierten Stadium (FIGO III/IV ...
Saner, Flurina, Mueller, Michael D.
core  

Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?

Cancer Treatment and Research Communications, 2022
Introduction: The role of a molecular pattern predictive of hyperthermic intraperitoneal chemotherapy (HIPEC) efficacy in advanced ovarian cancer (AOC) patients has been poorly investigated.
Valentina Ghirardi, Francesca De Felice, Marco D'Indinosante, Federica Bernardini, Maria Teresa Giudice, Anna Fagotti, Giovanni Scambia   +6 more
doaj   +1 more source

HIPEC and recurrent EOC.xls

, 2022
HIPEC and recurrent ...
Dong Yang (14177049)
core   +1 more source

Modeling of Chemoperfusion vs. Intravenous Administration of Cisplatin in Wistar Rats: Adsorption and Tissue Distribution

Molecules, 2020
Hyperthermic intraperitoneal chemoperfusion (HIPEC) is an established form of locoregional chemotherapy of peritoneum tumors. However, its efficacy and safety status remain a controversy, partially, due to scarce data on pharmacokinetics and toxicity ...
Galina Kireeva, Stepan Kruglov, Mikhail Maydin, Ekaterina Gubareva, Elena Fedoros, Ekaterina Zubakina, Natalya Ivanenko, Marina Bezruchko, Nikolay Solovyev   +8 more
doaj   +1 more source